Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership473,363 shares
Latest Disclosed Value $ 27,507,124
Franklin Resources Inc reports 40.82% increase in ownership of PCVX / Vaxcyte, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 473,363 shares of Vaxcyte, Inc. (US:PCVX) valued at $27,507,124 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 336,143 shares of Vaxcyte, Inc.. This represents a change in shares of 40.82% during the quarter. The current value of the position is $22,214,926 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F VAXCYTE COM 92243G108 473,363 137,220 40.82 27,507 77.36 0.0011
2026-02-11 2025-12-31 13F VAXCYTE COM 92243G108 336,143 37 0.01 15,510 28.11 0.0038
2025-11-13 2025-09-30 13F VAXCYTE COM 92243G108 336,106 -603,169 -64.22 12,107 -60.35 0.0030
2025-08-12 2025-06-30 13F VAXCYTE COM 92243G108 939,275 -2,149,757 -69.59 30,536 -73.82 0.0081
2025-05-13 2025-03-31 13F VAXCYTE COM 92243G108 3,089,032 219,700 7.66 116,642 -50.34 0.0336
2025-02-12 2024-12-31 13F VAXCYTE COM 92243G108 2,869,332 82,997 2.98 234,884 -25.47 0.0652
2024-11-27 2024-09-30 13F/A-1 VAXCYTE COM 92243G108 2,786,335 324,560 13.18 315,162 69.54 0.0885
2024-11-12 2024-09-30 13F VAXCYTE COM 92243G108 2,786,335 324,560 315,162 0.0152
2024-08-14 2024-06-30 13F VAXCYTE COM 92243G108 2,461,775 314,119 14.63 185,889 26.71 0.0571
2024-05-13 2024-03-31 13F VAXCYTE COM 92243G108 2,147,656 1,070,736 99.43 146,706 116.92 0.0465
2024-02-09 2023-12-31 13F VAXCYTE COM 92243G108 1,076,920 120,985 12.66 67,631 38.78 0.0316
2023-11-13 2023-09-30 13F VAXCYTE COM 92243G108 955,935 203,536 27.05 48,734 29.70 0.0248
2023-08-11 2023-06-30 13F VAXCYTE COM 92243G108 752,399 36,160 5.05 37,575 39.97 0.0179
2023-05-12 2023-03-31 13F VAXCYTE COM 92243G108 716,239 711,039 13,673.83 26,845 10,680.72 0.0135
2023-02-10 2022-12-31 13F VAXCYTE COM 92243G108 5,200 5,200 249 0.0001
2021-05-13 2021-03-31 13F VAXCYTE COM 92243G108 0 -400,076 -100.00 0 -100.00
2021-02-10 2020-12-31 13F VAXCYTE COM 92243G108 400,076 6 0.00 10,630 -46.19 0.0045
2020-11-12 2020-09-30 13F VAXCYTE COM 92243G108 400,070 0 0.00 19,755 55.62 0.0096
2020-08-13 2020-06-30 13F VAXCYTE COM 92243G108 400,070 400,070 12,694 0.0065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.